Tests an early lipid-lowering care program after heart-related hospital stays
Tests an early cholesterol-lowering support program in adults with heart disease in Asia-Pacific.
Plain-language title generated from the registry record
Registry title: Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Key facts
- Where
- Tainan, TaiwanSee the site
Where in Taiwan
- National Cheng Kung University HospitalTainan, TaiwanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Stephen Nicholls
- Trial code
- NCT05325034
- Record updated
- 8 October 2026
- Original description
Multinational, patient-level randomised, multi-phase standard-of-care control arm, parallel group, implementation study.Read full original descriptionShow less
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific (GOAL-ASIA)
Multinational, patient-level randomised, multi-phase standard-of-care control arm, parallel group, implementation study.
Patients will be recruited during hospitalisation and be randomised to a multifaceted intervention to be delivered either 'early' (baseline) or 'late' (6 months), in a 1:1 fashion.
Inclusion: 18 years of age; Admission for Type I myocardial infarction.
Exclusion: LDL <1.4mmol/L at baseline; Unable to provide contact details of primary care physician/general practitioner; Unable to provide written informed consent; Unlikely to survive >12 months.